Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Goodwill (2018 - 2025)

Historic Goodwill for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $37.4 billion.

  • Takeda Pharmaceutical's Goodwill rose 290.39% to $37.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $37.4 billion, marking a year-over-year increase of 290.39%. This contributed to the annual value of $35.0 billion for FY2025, which is 682.41% down from last year.
  • Takeda Pharmaceutical's Goodwill amounted to $37.4 billion in Q4 2025, which was up 290.39% from $36.9 billion recorded in Q3 2025.
  • In the past 5 years, Takeda Pharmaceutical's Goodwill registered a high of $38.1 billion during Q1 2021, and its lowest value of $33.2 billion during Q4 2022.
  • In the last 5 years, Takeda Pharmaceutical's Goodwill had a median value of $36.7 billion in 2021 and averaged $36.4 billion.
  • Its Goodwill has fluctuated over the past 5 years, first plummeted by 944.41% in 2022, then skyrocketed by 656.42% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Goodwill (Quarter) stood at $36.7 billion in 2021, then dropped by 9.44% to $33.2 billion in 2022, then rose by 4.14% to $34.6 billion in 2023, then rose by 5.04% to $36.3 billion in 2024, then rose by 2.9% to $37.4 billion in 2025.
  • Its last three reported values are $37.4 billion in Q4 2025, $36.9 billion for Q3 2025, and $36.6 billion during Q2 2025.